Harfst & Associates’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3M Buy
373,428
+1,413
+0.4% +$55.8K 2.39% 7
2026
Q1
$13.2M Buy
372,015
+16,794
+5% +$629K 2.36% 7
2025
Q4
$13.6M Buy
355,221
+34,417
+11% +$1.32M 2.45% 5
2025
Q3
$12.1M Buy
320,804
+10,432
+3% +$381K 2.23% 6
2025
Q2
$10.9M Buy
310,372
+185,376
+148% +$6.08M 2.26% 6
2025
Q1
$4.03M Buy
124,996
+52,175
+72% +$1.75M 0.93% 13
2024
Q4
$2.42M Buy
72,821
+53,986
+287% +$1.82M 0.5% 39
2024
Q3
$626K Buy
18,835
+10,962
+139% +$351K 0.14% 67
2024
Q2
$247K Buy
+7,873
New +$239K 0.06% 100

Other funds holding TCAF

Harfst & Associates's TCAF Position: Q2 2026 in Review

Harfst & Associates increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 0.38% in Q2 2026, buying an estimated $55.8K and bringing the position to 373,428 shares worth $15.3M. The position accounts for 2.39% of the portfolio, ranked #7.

Harfst & Associates first reported a position in TCAF in Q2 2024 and has held it in 9 quarters since. 357 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • Harfst & Associates held 373,428 shares of T. Rowe Price Capital Appreciation Equity ETF worth $15.3M as of Q2 2026.
  • Harfst & Associates bought 1,413 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $55.8K.
  • T. Rowe Price Capital Appreciation Equity ETF made up 2.39% of Harfst & Associates's portfolio in Q2 2026, its #7 holding.
  • Harfst & Associates first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q2 2024 and has held it in 9 quarters since.
  • 357 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on Harfst & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.